Drugs / Clade C and Mosaic gp140 HIV bivalent vaccine
Clade C and Mosaic gp140 HIV bivalent vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03964415 | Oct 2019 → Aug 2023 | — | Janssen Vaccines & Prevention B.V. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clade C and Mosaic gp140 HIV bivalent vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03964415 ↗ |
| Modality | Vaccine | “Clade C and Mosaic gp140 HIV bivalent vaccine” NCT03964415 ↗ |
| Route | Intramuscular | “Clade C and Mosaic gp140 HIV bivalent vaccine as IM injection into the deltoid muscle” NCT03964415 ↗ |